ID

17747

Description

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK This ODM contains Book 1/Visit 1.

Keywords

  1. 9/8/16 9/8/16 -
  2. 10/2/16 10/2/16 -
  3. 12/9/16 12/9/16 -
  4. 12/15/16 12/15/16 -
Uploaded on

October 2, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK

General Information
Description

General Information

Subject Identifier
Description

Subject Identifier

Data type

text

Visit Date
Description

Visit Description: Screening Protocol Identifier: AVA 100193

Data type

date

Demography
Description

Demography

Date of Birth
Description

Date of Birth

Data type

date

Sex
Description

Sex

Data type

text

Race
Description

Race

Data type

text

Alzheimer´s Disease Diagnosis and Course
Description

Alzheimer´s Disease Diagnosis and Course

Date of first symptoms
Description

Date of first symptoms

Data type

date

Date of diagnosis of probable AD
Description

Date of diagnosis of probable AD

Data type

date

Has there been a significant worsening in the past 6 month?
Description

Has there been a significant worsening in the past 6 month?

Data type

boolean

Is there any family history of AD? Parents/sibling/child?
Description

Is there any family history of AD?

Data type

text

Is there any family history of AD? Other relative
Description

Is there any family history of AD?

Data type

text

Vital Signs
Description

Vital Signs

Height
Description

Height

Data type

integer

Measurement units
  • cm
cm
Weight
Description

Weight

Data type

float

Measurement units
  • kg
kg
Blood pressure: Systolic
Description

Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.

Data type

integer

Blood pressure: Diastolic
Description

Blood pressure

Data type

integer

Measurement units
  • mmHg Sitting
mmHg Sitting
Heart rate
Description

Heart rate

Data type

integer

Measurement units
  • bpm
bpm
Education History
Description

Education History

How many full years of education did the subject complete? (include primary to post-university education)
Description

How many full years of education did the subject complete? (include primary to post-university education)

Data type

integer

Measurement units
  • years
years
Neurological Examination
Description

Neurological Examination

Results from Neurological Examination
Description

Results from Neurological Examination

Data type

text

History of Tobacco Use
Description

History of Tobacco Use

What is the subject´s history of tobacco use (include all tobacco products)?
Description

What is the subject´s history of tobacco use (include all tobacco products)?

Data type

text

If former smoker: When did the subject last smoke?
Description

If former smoker: When did the subject last smoke?

Data type

date

If current or former smoker: number of cigarettes smoked per day
Description

If current or former smoker: number of cigarettes smoked per day

Data type

integer

Measurement units
  • per day
per day
If current or former smoker: Number of years during which the subject has smoked?
Description

If current or former smoker: Number of years during which the subject has smoked?

Data type

integer

Medical Conditions
Description

Medical Conditions

Row number
Description

Row number

Data type

integer

Specific Condition
Description

Record only one condition per item.

Data type

text

Current
Description

Current

Data type

boolean

Past
Description

Past

Data type

boolean

Prior and Concomitant Medications
Description

Prior and Concomitant Medications

Drug Name (Trade Name preferred)
Description

Drug Name

Data type

text

Totally Daily Dose
Description

Totally Daily Dose

Data type

integer

Units (e.g mg)
Description

Units

Data type

text

Route
Description

Route

Data type

text

Reason for Medication
Description

Reason for Medication

Data type

text

Start Date
Description

Start Date

Data type

date

Stop Date
Description

Stop Date

Data type

date

Ongoing Medication
Description

Ongoing Medication

Data type

boolean

Central Laboratory (Fasting Samples)
Description

Central Laboratory (Fasting Samples)

Date samples taken
Description

Date samples taken

Data type

date

Pregnancy test
Description

Pregnancy test

Pregnant
Description

Results from Pregnancy Test

Data type

boolean

12-Lead-ECG
Description

12-Lead-ECG

Date of ECG
Description

Date of ECG

Data type

date

Result of ECG
Description

Result of ECG

Data type

text

HADS summary
Description

HADS summary

Depression score
Description

A score of 16-26 is required for a subject to be eligible for this study.

Data type

integer

MMSE summary
Description

MMSE summary

MMSE score
Description

MMSE score

Data type

integer

Echocardiogram
Description

Echocardiogram

Ejection fraction
Description

Ejection fraction

Data type

integer

Measurement units
  • %
%
Eligibility Question
Description

Eligibility Question

Did the subject meet all the entry criteria?
Description

Did the subject meet all the entry criteria?

Data type

boolean

Inclusion criteria
Description

Inclusion criteria

Male or female subject with a clinical diagnosis of probable (!) Alzheimer´s disease in accordance with NINCDS-ADRDA criteria. (Subject with a clinical diagnosis of possible Alzheimer´s disease are not eligible.)
Description

Inclusion

Data type

boolean

Subject has mild to moderate Alzheimer´s disease with MMSE score 16-26 inclusive at screening.
Description

Inclusion

Data type

boolean

Age 50 - 85 years.
Description

Inclusion

Data type

boolean

Prior and current medication is in accordance with the criteria on facing page.
Description

Inclusion

Data type

boolean

Female subjects must be post-menopausal (i.e > 6 month without menstrual period), surgically sterile, or if of child-bearing potential, using effective contraceptives measures (oral contraceptives, Norplant, Depo-Provera, an intra-uterine device (IUD), a diaphragm with spermicide or a condom with spermicide). Woman of childbearing potential must use effective contraceptive measures for at least one month prior to screening, and should continue to use the same contraceptive method during the study and for 30 days after discontinuing study medication.
Description

Inclusion

Data type

boolean

CT or MRI scan performed within the past 12 month or at screening, showing no evidence of tumor, other structural abnormality, or degenerative disease other than Alzheimer´s disease.
Description

Inclusion

Data type

boolean

Neurological exam without focal changes (excluding changes attributable to peripheral trauma).
Description

Inclusion

Data type

boolean

Subject has the ability to comply with procedures for cognitive and other testing.
Description

Inclusion

Data type

boolean

Subject lives with permanent caregiver who is willing wo attend all visits, oversees the subject´s compliance with protocol-specified procedures and study medication, and report on subject´s status. (Subjects living alone or in a nursing home are not eligible).
Description

Inclusion

Data type

boolean

Subject has provided full written informed consent prior to the performance of any protocol-specified procedure; or if unable to provide informed consent due to cognitive status, full written informed consent on behalf of the subject has been provided by a legally acceptable representative.
Description

Inclusion

Data type

boolean

Caregiver has provided full written informed consent on their own behalf prior to the performance of any protocol-specified procedure.
Description

Inclusion

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

History of Type I or Type II diabetes mellitus.
Description

Exclusion

Data type

boolean

Fasting plasma glucose level > 126 mg/dL (>7.0 mmol/L) or HbA 1c >6.2%
Description

Exclusion

Data type

boolean

History or clinical/laboratory evidence of moderate to severe congestive heart failure defined by the New York Heart Association criteria (class II-IV)
Description

Exclusion

Data type

boolean

Ejection fraction ≤ 40% determined by echocardiogram, or any other abnormality on echocardiography which in the view of the investigator required further investigation or intervention, or significant abnormalities on screening ECG (in accordance with definitions on facing page).
Description

Exclusion

Data type

boolean

Ejection fraction ≤ 40% determined by echocardiogram, or any other abnormality on echocardiography which in the view of the investigator required further investigation or intervention, or significant abnormalities on screening ECG (in accordance with definitions on facing page).
Description

Exclusion

Data type

boolean

History of new cardiovascular event within the last 6 month (i.e intervention, percutaneous coronary intervention, vascular surgery, acute coronary syndrome (non Q-wave myocardial infarction, Q-wave myocardial infarction, unstable angina) or significant arrhythmia; or major intervention (e.g cardiac surgery or angiography plus stenting) scheduled).
Description

Exclusion

Data type

boolean

History or clinical laboratory evidence of cerebrovascular disease (stroke, transient ischaemic attack, haemorrhage), or diagnosis of possible, probable or definite vascular dementia in accordance with NINDS-AIREN criteria.
Description

Exclusion

Data type

boolean

History or evidence of any other CNS disorder that could be interpreted as a cause of dementia: e.g structural abnormality, epilepsy, infectious or inflammatory/demyelinating CNS conditions, Parkinson´s disease.
Description

Exclusion

Data type

boolean

History of significant psychiatric illness such as schizophrenia or bipolar affective disorder, that in the opinion of the investigator would interfere with participation in the study, or current depression (score on Hospital Anxiety and Depression Scale (HADS) depression questions >7)
Description

Exclusion

Data type

boolean

Significant peripheral oedema at the time of screening.
Description

Exclusion

Data type

boolean

Systolic blood pressure > 165 mmHg or diastolic blood pressure > 95 mmHg whilst receiving optimal antihypertensive therapy according to local practice.
Description

Exclusion

Data type

boolean

Clinically significant anaemia (i.e. hemoglobin <11 g/dL for males or < 10 g/dL for females) or presence of haemoglobinopathies which would prevent accurate assessment of HbA 1c.
Description

Exclusion

Data type

boolean

Renal dysfunction, defined as creatinine clearance <30 ml/min (calculated from serum creatinine using the Cockcroft-Gault formula).
Description

Exclusion

Data type

boolean

ALT, AST, total bilirubin or alkaline phosphatase values > 2.5 times the upper limit of normal, or history of severe hepatobiliary disease (e.g hepatitis B or C, or cirrhosis).
Description

Exclusion

Data type

boolean

Fasting triglycerides > 12 mmol/L.
Description

Exclusion

Data type

boolean

Abnormal/positive result within the past 12 months or at screening for any of the following tests: vitamin B12, syphilis serology, thyroid stimulating hormone (TSH).
Description

Exclusion

Data type

boolean

History or presence of gastro-intestinal, hepatic or renal disease or other condition known to interfere with the absorption, distribution, metabolism or excretion of drugs, or any other clinically relevant abnormality, medical or psychiatric condition, which, in the opinion of the investigator, makes the subject unsuitable for inclusion in the study.
Description

Exclusion

Data type

boolean

Subject has given a blood donation of ≥ 450ml within the past 2 months.
Description

Exclusion

Data type

boolean

History of drug or alcohol abuse.
Description

Exclusion

Data type

boolean

Subject is unable (with assistance, if appropriate) to take study medication as prescribed throughout the study, has a history of non-compliance with prescribed medication, or is at risk of non-compliance with study medication or procedures.
Description

Exclusion

Data type

boolean

Subject is an immediate family member or employee of the participating investigator or of any of the participating site staff.
Description

Exclusion

Data type

boolean

Investigator´s Signature
Description

Investigator´s Signature

Investigator´s Signature
Description

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the data below.

Data type

text

Date
Description

Date

Data type

date

Investigator´s name (print)
Description

Investigator´s name (print)

Data type

text

Similar models

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
General Information
Subject Identifier
Item
Subject Identifier
text
Visit Date
Item
Visit Date
date
Item Group
Demography
Date of Birth
Item
Date of Birth
date
Item
Sex
text
Code List
Sex
CL Item
Male (1)
CL Item
Female (2)
Item
Race
text
Code List
Race
CL Item
Arabic/North Africa (1)
CL Item
Black (2)
CL Item
East & South East Asian (3)
CL Item
Japanese (4)
CL Item
South Asian (5)
CL Item
White/Caucasian (6)
CL Item
Other (7)
Item Group
Alzheimer´s Disease Diagnosis and Course
Date of first symptoms
Item
Date of first symptoms
date
Date of diagnosis of probable AD
Item
Date of diagnosis of probable AD
date
Has there been a significant worsening in the past 6 month?
Item
Has there been a significant worsening in the past 6 month?
boolean
Item
Is there any family history of AD? Parents/sibling/child?
text
Code List
Is there any family history of AD? Parents/sibling/child?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Is there any family history of AD? Other relative
text
Code List
Is there any family history of AD? Other relative
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Vital Signs
Height
Item
Height
integer
Weight
Item
Weight
float
Blood pressure
Item
Blood pressure: Systolic
integer
Blood pressure
Item
Blood pressure: Diastolic
integer
Heart rate
Item
Heart rate
integer
Item Group
Education History
How many full years of education did the subject complete? (include primary to post-university education)
Item
How many full years of education did the subject complete? (include primary to post-university education)
integer
Item Group
Neurological Examination
Results from Neurological Examination
Item
Results from Neurological Examination
text
Item Group
History of Tobacco Use
Item
What is the subject´s history of tobacco use (include all tobacco products)?
text
Code List
What is the subject´s history of tobacco use (include all tobacco products)?
CL Item
Never smoked (1)
CL Item
Current smoker (2)
CL Item
Former smoker (3)
If former smoker: When did the subject last smoke?
Item
If former smoker: When did the subject last smoke?
date
If current or former smoker: number of cigarettes smoked per day
Item
If current or former smoker: number of cigarettes smoked per day
integer
If current or former smoker: Number of years during which the subject has smoked?
Item
If current or former smoker: Number of years during which the subject has smoked?
integer
Item Group
Medical Conditions
Row number
Item
Row number
integer
Specific Condition
Item
Specific Condition
text
Current
Item
Current
boolean
Past
Item
Past
boolean
Item Group
Prior and Concomitant Medications
Drug Name
Item
Drug Name (Trade Name preferred)
text
Totally Daily Dose
Item
Totally Daily Dose
integer
Units
Item
Units (e.g mg)
text
Route
Item
Route
text
Reason for Medication
Item
Reason for Medication
text
Start Date
Item
Start Date
date
Stop Date
Item
Stop Date
date
Ongoing Medication
Item
Ongoing Medication
boolean
Item Group
Central Laboratory (Fasting Samples)
Date samples taken
Item
Date samples taken
date
Item Group
Pregnancy test
Results from Pregnancy Test
Item
Pregnant
boolean
Item Group
12-Lead-ECG
Date of ECG
Item
Date of ECG
date
Item
Result of ECG
text
Code List
Result of ECG
CL Item
Normal (1)
CL Item
Abnormal - not clinically significant (2)
CL Item
Abnormal - clinically significant (Assess eligibility and record abnormalities within the medical conditions item) (3)
Item Group
HADS summary
Depression score
Item
Depression score
integer
Item Group
MMSE summary
MMSE score
Item
MMSE score
integer
Item Group
Echocardiogram
Ejection fraction
Item
Ejection fraction
integer
Item Group
Eligibility Question
Did the subject meet all the entry criteria?
Item
Did the subject meet all the entry criteria?
boolean
Item Group
Inclusion criteria
Inclusion
Item
Male or female subject with a clinical diagnosis of probable (!) Alzheimer´s disease in accordance with NINCDS-ADRDA criteria. (Subject with a clinical diagnosis of possible Alzheimer´s disease are not eligible.)
boolean
Inclusion
Item
Subject has mild to moderate Alzheimer´s disease with MMSE score 16-26 inclusive at screening.
boolean
Inclusion
Item
Age 50 - 85 years.
boolean
Inclusion
Item
Prior and current medication is in accordance with the criteria on facing page.
boolean
Inclusion
Item
Female subjects must be post-menopausal (i.e > 6 month without menstrual period), surgically sterile, or if of child-bearing potential, using effective contraceptives measures (oral contraceptives, Norplant, Depo-Provera, an intra-uterine device (IUD), a diaphragm with spermicide or a condom with spermicide). Woman of childbearing potential must use effective contraceptive measures for at least one month prior to screening, and should continue to use the same contraceptive method during the study and for 30 days after discontinuing study medication.
boolean
Inclusion
Item
CT or MRI scan performed within the past 12 month or at screening, showing no evidence of tumor, other structural abnormality, or degenerative disease other than Alzheimer´s disease.
boolean
Inclusion
Item
Neurological exam without focal changes (excluding changes attributable to peripheral trauma).
boolean
Inclusion
Item
Subject has the ability to comply with procedures for cognitive and other testing.
boolean
Inclusion
Item
Subject lives with permanent caregiver who is willing wo attend all visits, oversees the subject´s compliance with protocol-specified procedures and study medication, and report on subject´s status. (Subjects living alone or in a nursing home are not eligible).
boolean
Inclusion
Item
Subject has provided full written informed consent prior to the performance of any protocol-specified procedure; or if unable to provide informed consent due to cognitive status, full written informed consent on behalf of the subject has been provided by a legally acceptable representative.
boolean
Inclusion
Item
Caregiver has provided full written informed consent on their own behalf prior to the performance of any protocol-specified procedure.
boolean
Item Group
Exclusion Criteria
Exclusion
Item
History of Type I or Type II diabetes mellitus.
boolean
Exclusion
Item
Fasting plasma glucose level > 126 mg/dL (>7.0 mmol/L) or HbA 1c >6.2%
boolean
Exclusion
Item
History or clinical/laboratory evidence of moderate to severe congestive heart failure defined by the New York Heart Association criteria (class II-IV)
boolean
Exclusion
Item
Ejection fraction ≤ 40% determined by echocardiogram, or any other abnormality on echocardiography which in the view of the investigator required further investigation or intervention, or significant abnormalities on screening ECG (in accordance with definitions on facing page).
boolean
Exclusion
Item
Ejection fraction ≤ 40% determined by echocardiogram, or any other abnormality on echocardiography which in the view of the investigator required further investigation or intervention, or significant abnormalities on screening ECG (in accordance with definitions on facing page).
boolean
Exclusion
Item
History of new cardiovascular event within the last 6 month (i.e intervention, percutaneous coronary intervention, vascular surgery, acute coronary syndrome (non Q-wave myocardial infarction, Q-wave myocardial infarction, unstable angina) or significant arrhythmia; or major intervention (e.g cardiac surgery or angiography plus stenting) scheduled).
boolean
Exclusion
Item
History or clinical laboratory evidence of cerebrovascular disease (stroke, transient ischaemic attack, haemorrhage), or diagnosis of possible, probable or definite vascular dementia in accordance with NINDS-AIREN criteria.
boolean
Exclusion
Item
History or evidence of any other CNS disorder that could be interpreted as a cause of dementia: e.g structural abnormality, epilepsy, infectious or inflammatory/demyelinating CNS conditions, Parkinson´s disease.
boolean
Exclusion
Item
History of significant psychiatric illness such as schizophrenia or bipolar affective disorder, that in the opinion of the investigator would interfere with participation in the study, or current depression (score on Hospital Anxiety and Depression Scale (HADS) depression questions >7)
boolean
Exclusion
Item
Significant peripheral oedema at the time of screening.
boolean
Exclusion
Item
Systolic blood pressure > 165 mmHg or diastolic blood pressure > 95 mmHg whilst receiving optimal antihypertensive therapy according to local practice.
boolean
Exclusion
Item
Clinically significant anaemia (i.e. hemoglobin <11 g/dL for males or < 10 g/dL for females) or presence of haemoglobinopathies which would prevent accurate assessment of HbA 1c.
boolean
Exclusion
Item
Renal dysfunction, defined as creatinine clearance <30 ml/min (calculated from serum creatinine using the Cockcroft-Gault formula).
boolean
Exclusion
Item
ALT, AST, total bilirubin or alkaline phosphatase values > 2.5 times the upper limit of normal, or history of severe hepatobiliary disease (e.g hepatitis B or C, or cirrhosis).
boolean
Exclusion
Item
Fasting triglycerides > 12 mmol/L.
boolean
Exclusion
Item
Abnormal/positive result within the past 12 months or at screening for any of the following tests: vitamin B12, syphilis serology, thyroid stimulating hormone (TSH).
boolean
Exclusion
Item
History or presence of gastro-intestinal, hepatic or renal disease or other condition known to interfere with the absorption, distribution, metabolism or excretion of drugs, or any other clinically relevant abnormality, medical or psychiatric condition, which, in the opinion of the investigator, makes the subject unsuitable for inclusion in the study.
boolean
Exclusion
Item
Subject has given a blood donation of ≥ 450ml within the past 2 months.
boolean
Exclusion
Item
History of drug or alcohol abuse.
boolean
Exclusion
Item
Subject is unable (with assistance, if appropriate) to take study medication as prescribed throughout the study, has a history of non-compliance with prescribed medication, or is at risk of non-compliance with study medication or procedures.
boolean
Exclusion
Item
Subject is an immediate family member or employee of the participating investigator or of any of the participating site staff.
boolean
Item Group
Investigator´s Signature
Investigator´s Signature
Item
Investigator´s Signature
text
Date
Item
Date
date
Investigator´s name (print)
Item
Investigator´s name (print)
text

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial